|By Business Wire||
|August 12, 2014 03:56 AM EDT||
Research and Markets (http://www.researchandmarkets.com/research/4bzxnc/nanobiotechnology) has announced the addition of Jain PharmaBiotech's new report "Nanobiotechnology Applications, Markets and Companies" to their offering.
An increasing use of nanobiotechnology by the pharmaceutical and biotechnology industries is anticipated. Nanotechnology will be applied at all stages of drug development - from formulations for optimal delivery to diagnostic applications in clinical trials. Many of the assays based on nanobiotechnology will enable high-throughput screening. Some of nanostructures such as fullerenes are themselves drug candidates as they allow precise grafting of active chemical groups in three-dimensional orientations. The most important pharmaceutical applications are in drug delivery. Apart from offering a solution to solubility problems, nanobiotechnology provides and intracellular delivery possibilities. Skin penetration is improved in transdermal drug delivery. A particularly effective application is as nonviral gene therapy vectors. Nanotechnology has the potential to provide controlled release devices with autonomous operation guided by the needs.
Future nanobiotechnology markets are calculated on the basis of the background markets in the areas of application and the share of this market by new technologies and state of development at any given year in the future. This is based on a comprehensive and thorough review of the current status of nanobiotechnology, research work in progress and anticipated progress. There is definite indication of large growth of the market but it will be uneven and cannot be plotted as a steady growth curve. Marketing estimates are given according to areas of application, technologies and geographical distribution starting with 2013. The largest expansion is expected between the years 2018 and 2023.
Profiles of 247 companies, out of over 500 involved in this area, are included in the last chapter along with their 17 collaborations. The report is supplemented with 41 Tables, 24 figures and 800 references to the literature.
Key Topics Covered:
3. Nanotechnologies for Basic Research Relevant to Medicine
4. Nanomolecular Diagnostics
6. Role of Nanotechnology in Biological Therapies
7. Nanodevices & Techniques for Clinical Applications
15. Miscellaneous Healthcare Applications of Nanobiotechnology
16. Nanobiotechnology and Personalized Medicine
18. Ethical and Regulatory Aspects of Nanomedicine
19. Research and Future of Nanomedicine
20. Nanobiotechnology Markets
For more information visit http://www.researchandmarkets.com/research/4bzxnc/nanobiotechnology
Source: Jain PharmaBiotech
Jan. 26, 2015 03:00 AM EST Reads: 1,422
Jan. 26, 2015 02:00 AM EST Reads: 2,707
Jan. 26, 2015 02:00 AM EST Reads: 2,372
Jan. 26, 2015 01:00 AM EST Reads: 2,520
Jan. 26, 2015 12:45 AM EST Reads: 3,461
Jan. 26, 2015 12:00 AM EST Reads: 2,144
Jan. 26, 2015 12:00 AM EST Reads: 2,195
Jan. 25, 2015 11:45 PM EST Reads: 1,783
Jan. 25, 2015 10:30 PM EST Reads: 1,772
Jan. 25, 2015 07:45 PM EST Reads: 2,326
Jan. 25, 2015 07:00 PM EST Reads: 1,247
Jan. 25, 2015 06:30 PM EST Reads: 1,585
Jan. 25, 2015 06:15 PM EST Reads: 3,806
Jan. 25, 2015 06:00 PM EST Reads: 1,422
Dale Kim is the Director of Industry Solutions at MapR. His background includes a variety of technical and management roles at information technology companies. While his experience includes work with relational databases, much of his career pertains to non-relational data in the areas of search, content management, and NoSQL, and includes senior roles in technical marketing, sales engineering, and support engineering. Dale holds an MBA from Santa Clara University, and a BA in Computer Science f...
Jan. 25, 2015 06:00 PM EST Reads: 3,011